Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2008
11/27/2008WO2007100775A3 Methods for regulating neurotransmitter systems by inducing counteradaptations
11/27/2008WO2007084743A3 Intraventricular protein delivery for amyotrophic lateral sclerosis
11/27/2008WO2007039864A3 The staudinger reaction in imaging and therapy and kits for use in imaging and therapy
11/27/2008US20080294035 Vessel size imaging for antiangiogenic therapy
11/27/2008US20080293921 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue
11/27/2008US20080293812 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
11/27/2008US20080292557 Compounds, compositions and methods for medical imaging of parkinson's disease
11/27/2008US20080292556 Target Vector with Activable Imaging Function
11/27/2008US20080292555 Quantitative Two-Photon Flow Cytometry
11/27/2008US20080292554 Cellular Labeling for Nuclear Magnetic Resonance Techniques
11/27/2008US20080292553 Phosphoramidate Derivatives of Fau
11/27/2008US20080292551 Method to Produce Hyperpolarised Carboxylates
11/27/2008US20080292547 Novel Imaging Agents for Fibrosis
11/27/2008US20080292545 Functionalized Encoded Apoferritin Nanoparticles and Processes for Making and Using Same
11/27/2008DE102007024470A1 New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis
11/27/2008CA2688811A1 Ophthalmic formulations of amyloid-beta contrast agents and methods of use thereof
11/27/2008CA2688146A1 Antibodies to il-6 and use thereof
11/27/2008CA2685826A1 Prokinetic agent for bowel preparation
11/26/2008EP1995321A2 Gene disruptions, compositions and methods relating thereto
11/26/2008EP1995315A2 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/26/2008EP1993614A2 Imaging agents comprising silicon
11/26/2008EP1993613A2 Chelating conjugates having a substituted aromatic moiety and derivatives thereof
11/26/2008EP1993447A2 Ultrasound molecular sensors and uses thereof
11/26/2008EP1809341A4 Truncated fragments of alpha-synuclein in lewy body disease
11/26/2008EP1663138B1 Dye composition and method for detection of demineralized lesions in teeth
11/26/2008EP1546373B1 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
11/26/2008EP1276492B1 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
11/26/2008EP0930844B8 Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent
11/26/2008CN201156044Y Apparatus for indicating Chinese herb nature
11/26/2008CN101310850A Preparation method and use method of polylactic acid tree-like molecule-modified magnetic nano particles
11/26/2008CN100435852C Method for the production of hyperpolarized 129xe
11/26/2008CN100435851C Method and its system for leading large molecular matter into target cell
11/26/2008CN100435721C Pharmaceutical in vivo dynamics characteristic-nondestructive in situ monitoring system and monitoring method
11/25/2008US7456333 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls.
11/25/2008US7456215 Pharmaceutical gallium compositions and methods
11/25/2008US7455845 Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure
11/25/2008CA2380766C Calcium complex of phosphorus containing diethylenetriamine derivatives
11/20/2008WO2008141111A2 Polymers conjugated with platinum drugs
11/20/2008WO2008141110A2 Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
11/20/2008WO2008141107A2 Compositions that include a hydrophobic compound and a polyamino acid conjugate
11/20/2008WO2008140624A2 Methods and compositions related to hybird nanoparticles
11/20/2008WO2008140475A2 Imaging contrast agents using nanoparticles
11/20/2008WO2008140081A1 Liposome and method for producing liposome
11/20/2008WO2008139480A2 Assessment of blood-brain barrier disruption
11/20/2008WO2008139207A2 Labelled hgf binding peptides for imaging
11/20/2008WO2008139206A2 Optical imaging agents
11/20/2008WO2008138141A1 Labelled adrenomedullin derivatives and their use for imaging and therapy.
11/20/2008WO2008138099A1 Sensory feedback-based method for determining the bioavailability of orally administered dietary supplements
11/20/2008WO2008106076A3 Methods for monitoring disease progression of alzheimer's disease using csf markers from longitudinal samples
11/20/2008WO2008095152A3 Methods and materials for identifying the origin of a carcinoma of unknown primary origin
11/20/2008WO2008025000A3 Imaging agents for functional imaging of lymphatic structures
11/20/2008WO2008022043A3 Intraoperative imaging of renal cortical tumors and cysts
11/20/2008WO2007097940A3 Reca inhibitors with antibiotic activity, compositions and methods of use
11/20/2008US20080289052 Method of Constructing Animal Having Cancer Cells Transplanted Thereinto
11/20/2008US20080287766 Integrated receiver for continuous analyte sensor
11/20/2008US20080287765 Integrated receiver for continuous analyte sensor
11/20/2008US20080287764 Integrated receiver for continuous analyte sensor
11/20/2008US20080286760 Means and Methods for the Determination of Camp In Vitro and In Vivo
11/20/2008US20080286370 Nanoscale Particles Used as Contrasting Agents in Magnetic Resonance Imaging
11/20/2008US20080286255 Treatment for eye disorder
11/20/2008US20080286208 Diagnosing the health of the eye by staining the tear film with a staining dye, everting the upper eyelid, and observing the lid wiper portion of the everted eyelid for infiltration of the staining dye into the cells thereof; dry eye diagnosis
11/20/2008US20080286206 Composition and Method for Medical Imaging of Body Cavities
11/20/2008US20080286205 Method for Treating Prostate Diseases Based on Local Delivery of Active Substances
11/20/2008US20080286204 Including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis
11/20/2008US20080286203 Inhibitors and Methods of Treatment of Cardiovascular Diseases, and Methods for Identifying Inhibitors
11/20/2008US20080286202 Administering 2-(4'-Nitrophenyl)-6-hydroxybenzothiazole radiolabeled with atri-alkyl tin or a chelating group; identifying amyloid deposition diseases in patients who present with a dementing disorder of questionable etiology
11/20/2008US20080284429 Situ Hyperpolarization of Imaging Agents
11/20/2008DE102007023491A1 Nanoscale hollow spheres having a specific range of outer diameter, inner diameter and wall thickness, useful as building material, filling material or construction material, as a radiopaque material in the ultrasound investigations
11/20/2008DE102007023256A1 Purifying fluoroalkyl- and fluoroacyl-compound, comprises providing solution of e.g. fluoroalkyl compound, leading this solution over first stationary phase, forwarding eluate over second stationary phase, washing and flowing from phase
11/20/2008DE102007020726A1 Auflage und Hülle Pad and Cover
11/20/2008CA2687106A1 Assessment of blood-brain barrier disruption
11/20/2008CA2686760A1 Labelled adrenomedullin derivatives and their use for imaging and therapy
11/20/2008CA2686089A1 Optical imaging agents
11/20/2008CA2685553A1 Peptide imaging agents
11/20/2008CA2683590A1 Compositions that include a hydrophobic compound and a polyamino acid conjugate
11/20/2008CA2663770A1 Imaging contrast agents using nanoparticles
11/19/2008EP1992957A2 Method for estimating the physiological parameters defining the edema induced upon infusion of fluid from an intraparenchymally placed catheter
11/19/2008EP1992371A1 Bio reabsorbable polymer materials opaque to X-rays and occlusion instruments made thereof
11/19/2008EP1992370A2 Medical devices visible under magnetic resonance imaging
11/19/2008EP1992339A1 Use of a magnesium isotope for treating hypoxia and a medicament comprising the same
11/19/2008EP1991703A2 A method for noninvasively and quantitatively monitoring therapeutic and diagnostic transgene expression induced by ex vivo and in vivo gene targeting in organs, tissues and cells
11/19/2008EP1991503A2 Superparamagnetic nanoparticles based on iron oxides with modified surface, method of their preparation and application
11/19/2008EP1991278A2 Multimodal imaging using a three compartment polymer nanoparticle with cell specificity
11/19/2008EP1991120A2 Nanoparticulate probe for in vivo monitoring of tissue oxygenation
11/19/2008EP1268775B1 The high bone mass gene of 11q13.3
11/19/2008CN101310011A Ex-vivo application of solid microparticulate therapeutic agents
11/19/2008CN101309976A High-purity texaphyrin metallic complex
11/19/2008CN101307018A Diethylene triaminepentaacetic acid carboxyl active ester or analogues, method for synthesizing same and use
11/18/2008US7452551 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a perfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image
11/18/2008CA2373993C Site specific binding system, nuclear imaging compositions and methods
11/18/2008CA2263924C Improved methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/18/2008CA2107884C Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract
11/13/2008WO2008137944A1 Methods and systems for coupling and focusing acoustic energy using a coupler member
11/13/2008WO2008137819A1 Methods of modulating binding of son of sevenless to phosphatide acid
11/13/2008WO2008137804A1 Quantum theory-based continuous precision nmr/mri: method and apparatus
11/13/2008WO2008136773A1 Functionalization of nanoparticles by glucosamine derivatives
11/13/2008WO2008076915A3 Treatment of pigs with pcv2 antigen
11/13/2008WO2008073988A3 Nmdar biomarkers for diagnosis and treatment of traumatic brain injury and other disorders
11/13/2008WO2008067049A3 Particles for cell targeting
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 354